Future studies involving metabolic flux analysis, DNA damage assays, and drug treatment experiments are warranted to explore these hypotheses and further elucidate the mechanistic roles of GNAI1 and GNAI2 in colorectal cancer biology and therapy response. The gene discussed is GNAI1; the disease is colorectal cancer.